JAGX adds infant patient for compassionate-use Crofelemer in intestinal failure
Jaguar Health says an additional infant patient will receive crofelemer through compassionate use for treatment of intestinal failure.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Jaguar Health says an additional infant patient will receive crofelemer through compassionate use for treatment of intestinal failure.